Home Acknowledgement
Article
Licensed
Unlicensed Requires Authentication

Acknowledgement

Published/Copyright: September 21, 2011

Published Online: 2011-9-21
Published in Print: 2005-12-1

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Contents Volume 43, 2005
  2. Author Index
  3. Subject Index
  4. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics
  5. Protein profiling as a diagnostic tool in clinical chemistry: a review
  6. Protein biochip systems for the clinical laboratory
  7. Automation of biochip array technology for quality results
  8. SELDI-TOF-MS proteomics of breast cancer
  9. Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development
  10. Separation of human serum proteins using the Beckman-Coulter PF2D™ system: analysis of ion exchange-based first dimension chromatography
  11. Rapid, accurate genotyping of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 based on the use of denaturing HPLC
  12. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals
  13. Simple PCR heteroduplex, SSCP mutation screening methods for the detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus
  14. Glycogen phosphorylase BB in acute coronary syndromes
  15. Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats
  16. Glycemic control in diabetes in three Danish counties
  17. Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells
  18. Buprenorphine detection in biological samples
  19. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population
  20. High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation
  21. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology
  22. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis
  23. Acknowledgement
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.240/html
Scroll to top button